Virtus Fund Advisers, LLC Enanta Pharmaceuticals Inc Transaction History

Virtus Fund Advisers, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $846,571 - $1.25 Million	-17,531 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$45.65 - $59.37 $800,290 - $1.04 Million	17,531	17,531 $1.03 Million

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $124M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Virtus Fund Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus Fund Advisers, LLC with notifications on news.